| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |